Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

437 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Budesonide and inflammatory bowel disease].
Gomollón F, Hinojosa J, Nos P. Gomollón F, et al. Among authors: hinojosa j. Gastroenterol Hepatol. 1999 Dec;22(10):525-32. Gastroenterol Hepatol. 1999. PMID: 10650668 Review. Spanish. No abstract available.
[Recommendations for the use of infliximab (Remicade) in Crohn's disease. GETECCU 2001].
Domènech E, Esteve-Comas M, Gomollón F, Hinojosa J, Obrador A, Panés J, Gassull MA; Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU). Domènech E, et al. Among authors: hinojosa j. Gastroenterol Hepatol. 2002 Mar;25(3):162-9. doi: 10.1016/s0210-5705(02)79012-2. Gastroenterol Hepatol. 2002. PMID: 11864540 Spanish. No abstract available.
[Consensus document on the use of granulocytapheresis in patients with inflammatory bowel disease].
Cabriada JL, Doménech E, Gomollón F, González-Carro P, González-Lara V, Hinojosa J, Jiménez-López CE, Nos P, Obrador A, Panès J, Saro C, Varea V, Lafuente R, Guilera M. Cabriada JL, et al. Among authors: hinojosa j. Gastroenterol Hepatol. 2006 Feb;29(2):85-92. doi: 10.1157/13083905. Gastroenterol Hepatol. 2006. PMID: 16448611 Spanish. No abstract available.
Risk of Immunomediated Adverse Events and Loss of Response to Infliximab in Elderly Patients with Inflammatory Bowel Disease: A Cohort Study of the ENEIDA Registry.
Calafat M, Mañosa M, Ricart E, Nos P, Iglesias-Flores E, Vera I, López-Sanromán A, Guardiola J, Taxonera C, Mínguez M, Martín-Arranz MD, de Castro L, de Francisco R, Rivero M, Garcia-Planella E, Calvet X, García-López S, Márquez L, Gomollón F, Barrio J, Esteve M, Muñoz F, Gisbert JP, Gutiérrez A, Hinojosa J, Argüelles-Arias F, Busquets D, Bujanda L, Pérez-Calle JL, Sicilia B, Merino O, Martínez P, Bermejo F, Lorente R, Barreiro-de Acosta M, Rodríguez C, Fe García-Sepulcre M, Monfort D, Cañete F, Domènech E; ENEIDA Study Group of GETECCU. Calafat M, et al. Among authors: hinojosa j. J Crohns Colitis. 2022 Jul 14;16(6):946-953. doi: 10.1093/ecco-jcc/jjab213. J Crohns Colitis. 2022. PMID: 34864947
[Steroids: friends or foes?].
Gomollón F, Hinojosa J. Gomollón F, et al. Among authors: hinojosa j. Gastroenterol Hepatol. 2008 Sep;31 Suppl 3:1-2. Gastroenterol Hepatol. 2008. PMID: 19087856 Spanish. No abstract available.
Therapeutic guidelines on ulcerative colitis: a GRADE methodology based effort of GETECCU.
Gomollón F, García-López S, Sicilia B, Gisbert JP, Hinojosa J; Grupo Espa˜nol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa. Gomollón F, et al. Among authors: hinojosa j. Gastroenterol Hepatol. 2013 Feb;36(2):104-14. doi: 10.1016/j.gastrohep.2012.09.006. Epub 2013 Jan 14. Gastroenterol Hepatol. 2013. PMID: 23332546
Colitis ulcerosa en 2011: mucho que mejorar.
Gomollón F, Hinojosa J. Gomollón F, et al. Among authors: hinojosa j. Gastroenterol Hepatol. 2011 Dec;34 Suppl 3:1-3. doi: 10.1016/S0210-5705(11)70091-7. Epub 2014 Oct 30. Gastroenterol Hepatol. 2011. PMID: 25443219 Spanish. No abstract available.
437 results